SOPHIE EUSEBIO-PEREA: Open Payments
NPI 1962805465 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,431 in 65 payments from 13 companies in 2025. Trend: 2023 $1,542 · 2024 $1,503 · 2025 $1,431
Food & beverage: $1,431
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $362 |
| Novartis Pharmaceuticals Corporation | 11 | $228 |
| Regeneron Healthcare Solutions, Inc. | 4 | $198 |
| LEO Pharma Inc. | 4 | $101 |
| GENZYME CORPORATION | 3 | $97 |
| Janssen Biotech, Inc. | 4 | $79 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $68 |
| PFIZER INC. | 3 | $63 |
| Amgen Inc. | 3 | $57 |
| Galderma Laboratories, L.P. | 3 | $56 |
Products named: DUPIXENT, SKYRIZI, RINVOQ, COSENTYX, TREMFYA, ADBRY, OTEZLA, NEMLUVIO.
Industry payments across FL — which companies pay providers there.
